Neuroone Medical Technologies (NMTC) Asset Utilization Ratio (2020 - 2025)
Neuroone Medical Technologies (NMTC) has disclosed Asset Utilization Ratio for 11 consecutive years, with 0.9 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio fell 7.11% year-over-year to 0.9, compared with a TTM value of 0.9 through Dec 2025, down 7.11%, and an annual FY2025 reading of 1.13, up 119.63% over the prior year.
- Asset Utilization Ratio was 0.9 for Q4 2025 at Neuroone Medical Technologies, up from 0.84 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.05 in Q1 2025 and bottomed at 0.01 in Q1 2021.
- Average Asset Utilization Ratio over 5 years is 0.39, with a median of 0.24 recorded in 2023.
- The sharpest move saw Asset Utilization Ratio crashed 36.02% in 2021, then skyrocketed 1908.19% in 2023.
- Year by year, Asset Utilization Ratio stood at 0.01 in 2021, then soared by 100.53% to 0.02 in 2022, then soared by 1704.59% to 0.4 in 2023, then soared by 139.58% to 0.97 in 2024, then fell by 7.11% to 0.9 in 2025.
- Business Quant data shows Asset Utilization Ratio for NMTC at 0.9 in Q4 2025, 0.84 in Q3 2025, and 0.87 in Q2 2025.